// App-Quantinova.ai

P375 : Inflammatory cutaneous lesions in inflammatory bowel disease treated with vedolizumab or ustekinumab: an ECCO CONFER multi-centre case series

Researchers

Presenter

  • F M Phillips

Principal Investigators

  • B Verstockt

  • S Sebastian

  • D G Ribaldone

  • S Vavricka

  • K Konstantinos

  • E Slattery

  • N de Suray

  • C Flores

  • W Fries

  • F Vincenzi

  • E Capoferro

  • O Bachmann

  • U Kopylov

Medical Centers

  • St Mark's Hospital, Inflammatory Bowel Disease Unit, London, United Kingdom

  • University Hospital CHU of Liege, Gastroenterology, Liege, Belgium

  • KU Leuven Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), Leuven, Belgium

  • Hull and East Yorkshire Hospitals NHS Trust, Inflammatory Bowel Disease Unit, Hull, UK

  • University of Hull and York, Hull York Medical School, Hull, UK

  • University of Turin, Surgical Sciences, Turin, Italy

  • University Hospital of Zurich, Zurich, Switzerland

  • University of Ioannina School of Medical Sciences, Gastroenterology, Ioannina, Greece

  • University Hospital Galway , Galway , Ireland

  • CHU de Charleroi, Department of Pneumology, Charleroi, Belgium

  • University Hospital Saint-Luc, Gastroenterology and Hepatology, Bruxelles, Belgium

  • Hospital De Clinicas de Porto Alegre, Porto Alegre RS, Brazil

  • University of Messina, Clinical Unit for Chronic Bowel Disorders, Messina, Italy

  • University of Parma, Gastroenterology and Endoscopy Unit, Parma, Italy

  • Sacro Cuore Don Calabria of Negrar, Negrar, Italy

  • Hannover Medical School, Department of Gastroenterology, Hepatology, and Endocrinology, Hannover, Germany

  • Sheba Medical Center, Department of Gastroenterology, Tel Hashomer, Israel

Locations

  • United Kingdom

  • Belgium

  • Italy

  • Switzerland

  • Greece

  • Ireland

  • Brazil

  • Germany

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Autoimmune (AI)

  • Genetic Disorder

  • Gastroenterology (GU)

Disease

  • Inflammatory bowel disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

  • Ustekinumab

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved